ARRIVENT BIOPHARMA, INC.
Asset & Liabilities Breakdown
Asset Breakdown FY2025
Total Assets: $333.2M
Liabilities Breakdown FY2025
Total Liabilities: $25.9M
Asset Breakdown
Total Assets: $333.2M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $45.5M | 13.7% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $0 | 0.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $287.6M | 86.3% |
Liabilities Breakdown
Total Liabilities: $25.9M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $5.9M | 22.9% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $20.0M | 77.1% |